Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > SO IM MISSING THE GOOD NEWS

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Aug 13, 2024 10:13pm

151 Views

Post# 36177785

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:SO IM MISSING THE GOOD NEWS

This would require IV therapy with rutherrin which is a different compount. So ruvidar, approved, can't jump from bladder med to IV med. Good thought.

The big plan would be to show efficacy at gbm and nsclc and then at that point you could tally up approvals for just about any cancer that likes iron (they all do, especially solid ones).

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles